APA (7th ed.) Citation

M, L., C, F., Y, L., Y, C., & J, P. (2026). A real-world pharmacovigilance study of FDA adverse event reporting system (FAERS) events for cabazitaxel. Naunyn-Schmiedeberg's archives of pharmacology, 399(3), 4547. https://doi.org/10.1007/s00210-025-04646-2

Chicago Style (17th ed.) Citation

M, Luo, Feng C, Lin Y, Chen Y, and Pang J. "A Real-world Pharmacovigilance Study of FDA Adverse Event Reporting System (FAERS) Events for Cabazitaxel." Naunyn-Schmiedeberg's Archives of Pharmacology 399, no. 3 (2026): 4547. https://doi.org/10.1007/s00210-025-04646-2.

MLA (9th ed.) Citation

M, Luo, et al. "A Real-world Pharmacovigilance Study of FDA Adverse Event Reporting System (FAERS) Events for Cabazitaxel." Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 399, no. 3, 2026, p. 4547, https://doi.org/10.1007/s00210-025-04646-2.